← Back to Clinical Trials
Recruiting NCT07444697

"Erectile Function After PCI in MI and Non-MI Patients"

Trial Parameters

Condition Erectile Disfunction
Sponsor Kırıkkale University
Study Type OBSERVATIONAL
Phase N/A
Enrollment 100
Sex MALE
Min Age 30 Years
Max Age 75 Years
Start Date 2026-01-15
Completion 2026-11

Brief Summary

The goal of this observational study is to assess changes in patients' erectile function after percutaneous coronary intervention (PCI) using a standard IIEF (International Index of Erectile Function) questionnaire at 1, 3, and 6 months post-PCI. By doing this, we try to compare patients' responses to PCI after having a heart attack and stable angina to see the real effect of myocardial infarction on erectile function status in the long term by comparing it with a very similar group.

Eligibility Criteria

Inclusion Criteria * Male patients aged 30-75 years * Undergoing successful percutaneous coronary intervention (PCI) for one of the following: * Acute myocardial infarction (Group 1) * Stable angina (Group 2) * Hemodynamically stable after the PCI procedure * Survival of the index hospitalization * Ability to provide written informed consent * Sexually active within the 3 months prior to enrollment * Willingness and ability to complete follow-up visits and questionnaires at: * Baseline (post-PCI recovery) * 3 months * 6 months Exclusion Criteria * Known malignancy (active or recently treated) * Neurological disorders affecting erectile function, including: * Spinal cord injury * Multiple sclerosis * Parkinson's disease * Uncontrolled diabetes mellitus (HbA1c \> 9%) * Presence of more than two chronic systemic diseases, such as: * Severe renal disease * Severe hepatic disease * Severe pulmonary disease * Polypharmacy, defined as chronic use of more than three daily medications * Absence

Related Trials